CINECA IRIS Institutional Research Information System

LUCCHI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.075
AS - Asia 9.508
EU - Europa 6.766
SA - Sud America 1.472
AF - Africa 440
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 8
Totale 36.304
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.563
SG - Singapore 3.193
CN - Cina 2.400
IT - Italia 2.051
HK - Hong Kong 1.549
BR - Brasile 1.237
DE - Germania 1.124
SE - Svezia 909
VN - Vietnam 836
BG - Bulgaria 545
GB - Regno Unito 408
FR - Francia 378
CA - Canada 376
TR - Turchia 322
RU - Federazione Russa 270
UA - Ucraina 266
FI - Finlandia 253
IN - India 244
KR - Corea 191
AT - Austria 148
JP - Giappone 148
CI - Costa d'Avorio 144
BD - Bangladesh 125
IQ - Iraq 87
CH - Svizzera 69
AR - Argentina 64
MX - Messico 63
NL - Olanda 63
SN - Senegal 58
ZA - Sudafrica 58
PL - Polonia 57
ES - Italia 52
PK - Pakistan 50
SA - Arabia Saudita 45
UZ - Uzbekistan 44
VE - Venezuela 44
ID - Indonesia 38
BE - Belgio 37
JO - Giordania 33
MA - Marocco 33
EC - Ecuador 31
AU - Australia 30
CO - Colombia 30
KE - Kenya 27
EG - Egitto 26
IE - Irlanda 24
NG - Nigeria 24
PH - Filippine 21
AE - Emirati Arabi Uniti 18
CL - Cile 18
DZ - Algeria 18
NP - Nepal 18
AZ - Azerbaigian 15
MY - Malesia 15
PY - Paraguay 15
LT - Lituania 14
OM - Oman 14
IL - Israele 13
IR - Iran 13
JM - Giamaica 13
KZ - Kazakistan 12
TN - Tunisia 12
UY - Uruguay 12
CR - Costa Rica 11
PE - Perù 11
RO - Romania 11
AL - Albania 10
CZ - Repubblica Ceca 9
PT - Portogallo 9
DK - Danimarca 8
KG - Kirghizistan 8
RS - Serbia 8
BB - Barbados 7
ET - Etiopia 7
EU - Europa 7
HN - Honduras 7
AO - Angola 6
BO - Bolivia 6
EE - Estonia 6
LK - Sri Lanka 6
TH - Thailandia 6
AM - Armenia 5
BN - Brunei Darussalam 5
DO - Repubblica Dominicana 5
GR - Grecia 5
NI - Nicaragua 5
NZ - Nuova Zelanda 5
PA - Panama 5
PS - Palestinian Territory 5
TT - Trinidad e Tobago 5
BH - Bahrain 4
BY - Bielorussia 4
GE - Georgia 4
LB - Libano 4
LV - Lettonia 4
MD - Moldavia 4
QA - Qatar 4
TW - Taiwan 4
BA - Bosnia-Erzegovina 3
BJ - Benin 3
Totale 36.234
Salva come PNG Salva come JPEG
Città #
Ashburn 1.914
Singapore 1.747
Woodbridge 1.558
Hong Kong 1.527
Fairfield 1.448
Houston 1.122
San Jose 1.058
Dallas 1.012
Santa Clara 960
Chandler 958
Ann Arbor 813
Seattle 624
Sofia 542
Cambridge 532
Shanghai 530
Wilmington 500
Beijing 493
New York 405
Milan 331
Boardman 314
Los Angeles 298
Ottawa 276
Hefei 242
Princeton 238
Pisa 233
Jacksonville 232
Lawrence 221
Florence 216
Ho Chi Minh City 213
Lauterbourg 210
Medford 195
Council Bluffs 182
Seoul 180
Izmir 172
Serra 172
Hanoi 165
Nanjing 159
Des Moines 147
Abidjan 144
Frankfurt am Main 133
Tokyo 131
Munich 126
Vicopisano 126
São Paulo 122
Vienna 117
Buffalo 102
Istanbul 101
Redondo Beach 99
San Diego 91
Dearborn 85
London 77
Columbus 72
Bremen 67
Boulder 63
Nanchang 62
The Dalles 60
Bern 59
Rome 59
Dakar 58
Dong Ket 58
Ogden 56
Helsinki 54
Turku 50
Paris 49
Kunming 47
Chicago 45
Pune 45
Warsaw 44
Tashkent 40
Nuremberg 39
Jüchen 38
Rio de Janeiro 38
Baghdad 37
Lancaster 37
Orem 37
Brussels 35
Falls Church 35
Montreal 34
Phoenix 32
Johannesburg 31
Da Nang 30
Amman 29
Dhaka 29
Redwood City 29
Tianjin 29
Shenyang 28
Toronto 28
Atlanta 27
Fuzhou 27
Lucca 27
Belo Horizonte 26
Chennai 26
Turin 26
Cascina 25
Nairobi 25
Porto Alegre 25
Haiphong 24
Jiaxing 24
Hebei 23
Denver 22
Totale 25.503
Salva come PNG Salva come JPEG
Nome #
null 346
Expression status of candidate genes in mesothelioma tissues and cell lines 341
A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy people 307
La densità microvascolare (DMV) come marker prognostico e predittivo nelle neoplasie maligne dell'albero bronchiale in fase avanzata. 298
Diaphragm and lung-preserving surgery with hyperthermic chemotherapy for malignant pleural mesothelioma: A 10-year experience 253
Malignant pleural mesothelioma and mesothelial hyperplasia: A new molecular tool for the differential diagnosis 244
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study 228
Serum mesothelin, osteopontin and vimentin: useful markers for clinical monitoring of malignant pleural mesothelioma 223
Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance 221
Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism 221
Percutaneous radiofrequency ablation (pRTA) of pulmonary tumors 215
EGFR and KRAS mutational analysis in a large series of Italian non-small cell lung cancer patients: 2,387 cases from a single center 212
210P: Digital gene expression profiling to separate malignant pleural mesothelioma from benign reactive mesothelial hyperplasia 211
Distinct Angiogenic microRNA-mRNA Expression Profiles Among Subtypes of Lung Adenocarcinoma. 206
Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicopathological and molecular features 198
Association of the DNMT3B -579G>T polymorphism with risk of thymomas in patients with myasthenia gravis. 197
Surgical treatment of pleural recurrence from thymoma 194
TERMOABLAZIONE DI NEOPLASIE POLMONARI MALIGNE: QUALI PROSPETTIVE 193
Second primary lung cancer and relapse: treatment and follow-up. 192
Screen-detected multiple primary lung cancers in the ITALUNG trial 192
Advanced stage thymomas and thymic carcinomas: results of multimodality treatments 191
Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial 191
Whole transcriptome targeted gene quantification provides new insights on pulmonary sarcomatoid carcinomas 191
Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study 191
A high vascular count and overexpression of Vascular Endothelial Growth Factor (VEGF) are associated with unfavorable prognosis in operated Small Cell Carcinoma (SCLC) 190
A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma 190
Differential microRNA expression profiles between young and old lung adenocarcinoma patients. 186
Comparative analysis of genetic variants in pleural fluids and solid tissue biopsies of pleural mesothelioma patients: Implications for molecular heterogeneity assessment 183
The thymidylate synthase enhancer region (TSER) polymorphism increases the risk of thymic lymphoid hyperplasia in patients with Myasthenia Gravis 183
Comparison between plasma and serum osteopontin levels: usefulness in diagnosis of epithelial malignant pleural mesothelioma 182
Metachronous adrenal masses in resected non-small cell lung cancer patients:therapeutic implications of laparoscopic adrenalectomy 182
Resection of single brain metastasis in non-small-cell lung cancer: prognostic factors. 181
Four thymus-related syndromes in a case of invasive thymoma 181
Alterations of Fas (APO-1/CD95) gene and its relationship with p53 in non small cell lung cancer 181
Applications of tissue microarray technology in immunohistochemistry: a study on c-kit expression in small cell lung cancer 181
2ND PRIMARY LUNG-CANCER AND RELAPSE - TREATMENT AND FOLLOW-UP 179
ALK rearrangement in a large series of consecutive non-small cell lung cancers: Comparison between a new immunohistochemical approach and fluorescence in situ hybridization for the screening of patients eligible for crizotinib treatment 179
Neoangiogenesis and p53 protein in lung cancer: Their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression 177
Multimodal lung cancer screening using the ITALUNG Biomarker Panel and Low Dose Computed Tomography. Results of the ITALUNG biomarker study 177
A gene-expression-based test can outperform bap1 and p16 analyses in the differential diagnosis of pleural mesothelial proliferations. 175
A reappraisal of the indications for laparoscopic treatment of adrenal metastases 174
Pre-operative chemotherapy for stage IIIa (N2) non-small cell lung cancer. 173
CERENKOV LUMINESCENCE IMAGING IN PULMONARY AND HEPATIC METASTASECTOMY 173
Accumulation of gene protein product P53 correlates with high microvessel count in non small cell lung carcinomas 172
Neoangiogenesis as prognostic indicator of survival in lung cancer. 172
Surgical treatment of NSCLC in octuagenarians. 171
KIF5B/RET fusion gene analysis in a selected series of cytological specimens of EGFR, KRAS and EML4-ALK wild-type adenocarcinomas of the lung 171
Expression Profiling of LKB1 Pathway in Young and Old Lung Adenocarcinoma Patients. 170
The multimodality treatment of thymic carcinoma 169
Neoangiogenesis: A putative marker of malignancy in non-small-cell lung cancer (NSCLC) development 169
Chest wall resection for mesothelioma recurrence after surgery 168
A strategy for thoracoscopic resection of small pulmonary nodules 168
A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma 167
Investigation of MLH1, MGMT, CDKN2A, and RASSF1A Gene Methylation in Thymomas From Patients With Myasthenia Gravis 166
[18F]FDG-PET/CT patterns of bone metastases in lung cancer 165
Hypertermic Intrathoracic Chemotherapy (HITHOC) for thymoma: a narrative review on indications and results 164
Expression profiling and microRNA regulation of the LKB1 pathway in young and aged lung adenocarcinoma patients 163
Gene-specific methylation analysis in thymomas of patients with myasthenia gravis 163
Favourable survival outcome in patients with SCLC treated by sequential intensive chemotherapy and high dose chest irradiation 162
Identification of Fas (APO-1/CD95) and p53 gene mutations in non-small cell lung cancer 162
New Keywords in the Treatment of Malignant Pleural Mesothelioma 162
Interleukin-8 in non-small cell lung carcinoma: relation with angiogenic pattern and p53 alterations 162
Pleural recurrence of thymoma: Surgical resection followed by hyperthermic intrathoracic perfusion chemotherapy 161
Presence and inter-individual variability of carboxylesterases (CES1 and CES2) in human lung 161
Intraoperative sentinel lymph node mapping in stage I non-small cell lung cancer: detection of micrometastases by polymerase chain reaction 160
TNM Staging System in Thymoma: A Critical Appraisal? 159
N2 lung cancer is not all the same: an analysis of different prognostic groups 159
Surgical treatment of non-small cell lung cancer in octogenarians 158
Robotic lobectomy for lung cancer: Evolution in technique and technology 158
Investigation of GHSR methylation levels in thymomas from patients with Myasthenia Gravis 157
Evaluation of the Incidence and Potential Mechanisms of Tracheal Complications in Patients With COVID-19 157
Imaging of malignant pleural mesothelioma: It is possible a screening or early diagnosis program? - A systematic review about the use of screening programs in a population of asbestos exposed workers 156
Endoscopic thymectomy: A neurologist's perspective 155
Polymer self-locking clips for vascular control during minimally invasive pulmonary lobectomies 154
WWOX expression in different histologic types and subtypes of non-small cell lung cancer 154
Surgical treatment of recurrent thymomas 153
Acute major airway injuries: clinical features and management 153
Radio-guided thoracoscopic surgery (RGTS) of small pulmonary nodules. 153
Ten-year experience of mediastinal robotic surgery in a single referral centre 153
Association of thymoma and myasthenia gravis: oncological and neurological results of the surgical treatment 153
Transcollation® technique in the thoracoscopic treatment of primary spontaneous pneumothorax 153
Massive pneumoencephalus of late onset after an en-bloc resection for lung cancer 152
Reply to heyman and van schil 151
Gastropleural fistula as complication of post-pneumonectomy empyema 150
Primary neuroendocrine tumors of the thymus: a multicenter experience of 35 patients. 149
MIB1 labelling does not affect metastasis and overall survival in non small cell lung carcinomas 148
Alterazioni del gene Fas (APO-1/CD95) nei carcinomi polmonari non a piccole cellule (NSCLC). Correlazioni con le alterazioni del gene P53. 148
Stereotactic body radiation therapy for the treatment of pleural metastases in patients with thymoma: A retrospective review of 22 patients 148
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors. 147
Gamma-probe guided thoracoscopic surgery of small pulmonary nodules 146
Robotic extended thymectomy for early-stage thymomas 146
Nerve-Sparing Surgery in Advanced Stage Thymomas 146
Video robotic lobectomy 145
Percutaneous radiofrequency ablation of primary NSCLC 145
Role of microRNA-33a in regulating the expression of PD-1 in lung adenocarcinoma. 145
Thymic carcinoma: a report of 13 cases 145
Liquid biopsies from pleural effusions and plasma from patients with malignant pleural mesothelioma: A feasibility study 143
Percutaneous radiofrequency ablation of primary NSCLC 142
Differential microRNA Expression Profile between Young and Old Lung Adenocarcinoma Patients. 142
Gene Expression Analysis of Biphasic Pleural Mesothelioma: New Potential Diagnostic and Prognostic Markers 142
Totale 17.796
Salva come PNG Salva come JPEG
Categoria #
all - tutte 105.875
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.875
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021395 0 0 0 0 0 0 0 0 0 0 115 280
2021/20222.660 23 170 97 130 487 371 139 124 165 149 132 673
2022/20233.053 369 375 229 289 307 413 42 219 549 11 221 29
2023/20242.234 199 193 236 269 306 394 120 79 41 40 117 240
2024/20258.504 153 301 74 464 821 758 674 420 916 1.039 956 1.928
2025/20269.422 600 1.152 1.157 839 968 876 1.751 457 588 964 70 0
Totale 36.790